misoprostol and Intestinal-Perforation

misoprostol has been researched along with Intestinal-Perforation* in 2 studies

Reviews

1 review(s) available for misoprostol and Intestinal-Perforation

ArticleYear
Nonsteroidal antiinflammatory drugs and the gastrointestinal tract.
    The Gastroenterologist, 1994, Volume: 2, Issue:3

    Nonsteroidal antiinflammatory drugs (NSAIDs) are used in large amounts for analgesic, antiinflammatory, and antithrombotic indications. This use is not without side effects on the gut and other organs, and some of these side effects may be serious and even lethal. No NSAID has been shown to be without side-effect potential. Use increases with age, and age poses additional risks to patients with side effects. The most serious side effects are perforation of peptic and gut ulcers and gastrointestinal (GI) bleeding, which NSAIDs, and especially acetylsalicylic acid (ASA; aspirin), may promote from both ulcer and nonulcer lesions of both the upper and lower GI tract (i.e., both acid- and nonacid-dependent). Upper GI mucosal lesions range from trivial--petechiae and superficial erosions--to significant and potentially serious deep (chronic) peptic ulcers, esophagitis, and, less commonly, small and large gut ulcers. Symptoms may occur independently of observable lesions, and serious lesions may occur without any prior symptoms. The risk of ulceration due to therapeutic doses of NSAIDs is estimated at 5- to 10-fold. NSAIDs also delay healing of conventional peptic ulcers. Moreover, ASA abuse, often surreptitious and discoverable by serum salicylate level measurement, may cause totally intractable gastric or duodenal ulceration. Surgery is contraindicated because relapse is inevitable and progressively more serious. The rational use of NSAIDs is discussed, and prophylactic and treatment strategies are proposed. None seems entirely satisfactory, and the best prophylaxis would be to avoid the use of NSAIDs except for proven indications. Until the mechanisms whereby NSAIDs both cause injury and provide therapeutic benefits can be separated, the problem of side effects and their prevention or treatment remains unresolvable.

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Digestive System; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Humans; Intestinal Perforation; Intestine, Large; Intestine, Small; Misoprostol; Omeprazole; Osteoarthritis; Peptic Ulcer; Sucralfate

1994

Other Studies

1 other study(ies) available for misoprostol and Intestinal-Perforation

ArticleYear
[Prevalence of illegal abortions in Libreville Hospital, Gabon].
    Bulletin de la Societe de pathologie exotique (1990), 2009, Volume: 102, Issue:4

    The objectives of this study were to determine the prevalence of illegal abortion in Libreville and to describe abortive methods used. It is a cross sectional and descriptive survey carried out at the maternity hospital of Libreville (MHL) during one year, from 1 January 2008 to 31 December 2008. 750 abortions were performed during this period and 651 cases were illegal abortions. Prevalence was of 86.7%. The women undergoing illegal abortion were most often pupils (67.1%), with an average age of 22.4 +/- 5.3 years old and a mean parity of 1.2 +/- 1.50. The average gestational term was of 7.4 +/- 1.9 weeks. Misoprostol (63.1%) was the most frequent abortive product used. 2 maternal deaths were notified. Prevalence of illegal abortions is increasing at the MHL. Up to now, misoprostol is the most frequent abortive product used.

    Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortion, Criminal; Adolescent; Adult; Cross-Sectional Studies; Endometritis; Female; Gabon; Gestational Age; Hospitals, Maternity; Humans; Intestinal Perforation; Medicine, African Traditional; Misoprostol; Parity; Pregnancy; Prevalence; Uterine Hemorrhage; Uterus; Young Adult

2009